Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04318977

rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
62 (actual)
Sponsor
University of Regensburg · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Treatment of depression with repetitive transcranial magnetic stimulation (rTMS) has shown high evidence using high-frequency left dorsolateral prefrontal cortex (DLPFC) stimulation. The treatment of negative symptoms with the same protocol in schizophrenia is considered as possible effective. Theta burst stimulation is a new protocol which is characterized by shorter sessions showing first evidence that it's efficacy is comparable to the high-frequency rTMS. In this randomized placebo-controlled study the efficacy of high-frequency rTMS and TBS are evaluated.

Detailed description

In this randomized placebo-controlled study the efficacy of high-frequency rTMS and TBS are evaluated. The active study arms are high-frequency rTMS and iTBS of the left dorsolateral prefrontal cortex to treat negative symptoms in schizophrenia. The control arm will include the same number of patients as each active arm and includes both sham rTMS and sham iTBS in the same proportion as the active treatments. Standards of the trial will be harmonized across four clinical centers with the aim to pool data for analysis. Each center is responsible for ethical approval and adherence to good clinical practice by itself (Sponsor). Interim analysis: Several meta-analyses of the effect of rTMS/iTBS on negative symptoms in schizophrenia showing heterogeneous effect sizes have been published since begin of the trial. Thefore, an interim analysis after inclusion of at least 15 patients in each arm was added to the protocol. In case of null findings and low effect sizes (no differences of either rTMS or TBS vs. sham in the primary outcome), the trial will be terminated.

Conditions

Interventions

TypeNameDescription
DEVICEhigh-frequency rTMSrepetitive transcranial magnetic stimulation
DEVICETBStheta burst stimulation
DEVICEplaceboplacebo transcranial magnetic stimulation

Timeline

Start date
2020-02-01
Primary completion
2024-08-14
Completion
2025-12-30
First posted
2020-03-24
Last updated
2025-09-19

Locations

4 sites across 2 countries: Czechia, Germany

Source: ClinicalTrials.gov record NCT04318977. Inclusion in this directory is not an endorsement.